Insulin Glargine (U-100) Cartridge Systems and Pens and Letermovir Intravenous
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Letermovir Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Letermovir oral/injection
- Insulin Glargine (U-100) Cartridge Systems and Pens-Letermovir Tablets
- Insulin Glargine (U-100) Cartridge Systems and Pens-Letrozole
- Insulin Glargine (U-100) Cartridge Systems and Pens-Letrozole and ribociclib
- Insulin Glargine (U-100) Cartridge Systems and Pens-Leucovorin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Leucovorin Calcium
- Letermovir Intravenous-Insulin Glargine (U-100) Vials
- Letermovir Intravenous-Insulin Glargine (U-300) Pens
- Letermovir Intravenous-Insulin glargine and lixisenatide
- Letermovir Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Letermovir Intravenous-Insulin glargine, recombinant Subcutaneous
- Letermovir Intravenous-Insulin glulisine